Victoza day 3: what liraglutide actually does to your body

What did @kennisue22 actually say?

On day three of Victoza (liraglutide), this creator described starting at the 0.6 mg dose, experiencing severe nausea on night one, then improving. She demonstrated her injection technique on camera, noted that the medication "kinda makes you queasy towards greasy foods," and shared a needle-recapping trick using the pen's blue top. She's managing type 2 diabetes at 182 pounds and plans weekly weight updates.

The video is a straightforward personal experience log, not a medical tutorial. She's not claiming to treat or cure anything, which puts it in a relatively low-risk category for health misinformation. Still, a few things in her demo deserve closer attention, and her needle disposal method is a genuine safety issue worth addressing directly.

Does the science back this up?

The nausea she described, feeling like she "went on a million carnival rides," is well-documented and not random bad luck. It reflects how liraglutide actually works. The drug slows gastric emptying and acts on GLP-1 receptors in the brainstem, areas directly involved in nausea signaling.

In the LEAD clinical trial program, gastrointestinal side effects, including nausea, vomiting, and diarrhea, were the most commonly reported adverse events with liraglutide, occurring in roughly 28-40% of patients during dose escalation (Garber et al., 2009, The Lancet). The standard titration protocol starts at 0.6 mg for one week precisely to reduce this GI burden before moving to therapeutic doses. Her report that night two went better is also consistent with the data: nausea typically peaks early and fades for most patients within the first few weeks. The appetite suppression she noticed around greasy foods aligns with GLP-1 receptor agonist mechanisms, reducing reward-driven eating and slowing gastric motility (van Can et al., 2014, Diabetes, Obesity and Metabolism).

What did they get right or wrong?

She got the dose right, 0.6 mg is the correct starting dose for Victoza. The injection technique she demonstrated, pinching a fold of fatty skin, injecting subcutaneously, and holding for five seconds, is consistent with manufacturer guidance. Credit where it's due.

The needle disposal method is where things go sideways. She recaps the needle by fitting it back into the pen cap and storing it attached to the pen. This is not safe sharps disposal. The FDA and CDC are unambiguous: used insulin and GLP-1 pen needles are regulated medical sharps and should go into a puncture-resistant sharps container, not loose in a pocket or stored recapped on a pen. Recapping needles is specifically flagged as a needlestick risk in clinical settings. If she's traveling or doesn't have a sharps container, FDA-approved travel cases and mail-back programs exist for exactly this situation. Presenting the recap trick as a "good way to save it" to 41,000 viewers, some of whom are likely new to injectable medications, is genuinely problematic.

What should you actually know?

If you're starting Victoza or any GLP-1 receptor agonist, the first week of nausea is real, common, and for most people, temporary. The 0.6 mg dose is not a therapeutic dose for blood sugar control or weight loss. It is a tolerance-building dose. Expecting weight loss results during week one sets people up for early disappointment and premature discontinuation.

Needle disposal matters more than most patient education covers. Used sharps in regular trash or recapped on pens create injury risk for household members, waste handlers, and sanitation workers. Many pharmacies offer free sharps containers or take-back programs. It takes about 30 seconds to ask at the counter when picking up your prescription.

Finally, this creator is documenting her personal experience with a legitimately prescribed medication for type 2 diabetes. That context is worth keeping. She is not selling anything, not claiming a cure, and not suggesting her experience applies universally. The most useful thing a viewer can take from this kind of video is that GLP-1 side effects are real and manageable, not that her injection routine is a clinical protocol to follow exactly.